Table 2 Calculations of degree based topological and Banhatti indices (decision matrix).

From: Ranking polycystic ovarian syndrome (PCOS) drugs using degree-based indices in QSPR models and CRITIC-driven MCDM methods

Drugs

M1

M2

Mm2

ReZG3

F

I

H

SDD

B1

B2

mB1

mB2

Metformin

36

42

2.11

174

94

7.65

3.6333

22.999

76

94

3.6855

5.5554

Letrozole

108

121

4.42

598

260

25

9.5

51.333

180

194

11.257

13.667

Ethinylestradiol

154

198

4.74

1236

480

33.431

9.7690

72.249

259

510

6.5848

7.0542

Levonorgestrel

136

177

4.78

1032

412

32.759

10.274

58.083

310

519

9.8916

9.2645

Spironolactone

168

197

6.15

1116

464

36.714

12.619

77.75

372

542

12.078

10.861

Dexamethasone

166

221

5.52

1380

528

37.221

10.729

79.334

378

638

10.912

10.999

Pioglitazone

126

143

5.61

690

312

30.067

11.800

60.999

262

346

11.419

10.722

Lorcaserin

66

76

2.89

376

166

15.7

6.066

31.667

142

186

5.8381

5.3333

Finasteride

191

245

2.89

1556

612

40.562

13.538

93.083

426

730

11.502

9.9458

Eflornithine

52

58

2.87

322

148

11.229

4.9714

30.749

112

163

5.1233

5.8375

Orlistat

148

159

8.31

732

344

34.486

16.067

75.333

308

366

15.371

17.388

Tasimelteon

96

115

4.03

584

244

23.217

8.5999

43.333

208

282

8.3095

7.8333

Flutamide

90

100

4.36

508

238

20.2

8.7222

49.667

178

226

9.8426

13.499

Rosiglitazone

126

143

5.56

692

312

30.05

11.767

60

270

346

11.305

9.9222

Oxandrolone

190

209

4.87

1322

518

34.712

10.405

102.25

417

620

9.4466

8.2788

Back to article page